Douglas T. Sheehy
2017 - Aimmune Therapeutics
In 2017, Douglas T. Sheehy earned a total compensation of $1.7M as General Counsel and Secretary at Aimmune Therapeutics.
Compensation breakdown
| Bonus | $58,000 |
|---|---|
| Non-Equity Incentive Plan | $155,600 |
| Option Awards | $1,158,858 |
| Salary | $360,250 |
| Total | $1,732,708 |
Sheehy received $1.2M in option awards, accounting for 67% of the total pay in 2017.
Sheehy also received $58K in bonus, $155.6K in non-equity incentive plan and $360.3K in salary.
Rankings
In 2017, Douglas T. Sheehy's compensation ranked 6,214th out of 14,666 executives tracked by ExecPay. In other words, Sheehy earned more than 57.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,214 out of 14,666 | 58th |
Division Manufacturing | 2,280 out of 5,768 | 61st |
Major group Chemicals And Allied Products | 721 out of 2,074 | 65th |
Industry group Drugs | 557 out of 1,730 | 68th |
Industry Pharmaceutical Preparations | 439 out of 1,329 | 67th |
Source: SEC filing on April 11, 2018.
Sheehy's colleagues
We found five more compensation records of executives who worked with Douglas T. Sheehy at Aimmune Therapeutics in 2017.
2017
Stephen Dilly
Aimmune Therapeutics
Chief Executive Officer
2017
Eric Bjerkholt
Aimmune Therapeutics
Chief Financial Officer
2017
Daniel Adelman
Aimmune Therapeutics
Chief Medical Officer
2017
Jeffrey Knapp
Aimmune Therapeutics
Chief Operating Officer
2017
Warren DeSouza
Aimmune Therapeutics